Top Medical News from Across Medscape

  • Cardiac Effects of Fingolimod in MS ReversibleFingolimod, used to treat multiple sclerosis, dampens cardiac autonomic modulation at rest and during challenges, but this effect appears to be reversible after discontinuation of the drug, a study shows.
  • Biologics Not Linked to Higher Cancer Risk in RAPatients with RA treated with biologic drugs had no overall increase in cancer risk compared with similar patients treated with conventional DMARDs, a study of nearly 70,000 patients has found.
  • Bariatric Surgery May Reduce Retinopathy Risk, ProgressionRoux-en-Y gastric bypass reduced diabetic retinopathy risk regardless of postsurgery diabetes status in a two-phase trial; a second study confirms obesity-related microvascular changes are reversible.
  • IBD in Childhood Raises Cancer RiskThe introduction of new drug therapies for inflammatory bowel disease does not seem to have changed the increased risk for cancer in this patient population.
  • Hurricane Relief Fund Created for Neurologists in NeedIn the wake of the destruction caused by recent hurricanes in the United States and its territories, the AAN has created a relief fund to help neurology practices that suffered loss or damage.

Special Report

  • Healthcare policy is the number one topic -- not just in Washington, DC but in hospitals, medical practices, and homes. With so much happening on so many fronts, it's hard to keep up. Let us do it for you.

Business of Medicine

  • Should Physicians Educate Patients via Social Media?   More patients are going online to get health information and some of the information on the Internet is not scientific. What can physicians do to educate patients via social media?
  • How Residents Cope: Bingeing, Drinking, Sports, and Friends Overeating. Drinking. Antidepressants. These are a few of the coping mechanisms residents rely on to get through their stressful residencies. Are there any positive coping strategies?

Medscape Editor-in-Chief

  • Eric J. Topol, MD Director, Scripps Translational Science Institute; Chief Academic Officer, Scripps Health; Professor of Genomics, The Scripps Research Institute, La Jolla, California